Previous Close | 19.18 |
Open | 19.27 |
Bid | 0.00 x 1000 |
Ask | 0.00 x 1200 |
Day's Range | 19.08 - 21.96 |
52 Week Range | 11.70 - 58.45 |
Volume | |
Avg. Volume | 612,104 |
Market Cap | 575.911M |
Beta (5Y Monthly) | 2.71 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for ARCT
Shareholders in Arcturus Therapeutics Holdings Inc. ( NASDAQ:ARCT ) may be thrilled to learn that the analysts have...
Arcturus Therapeutics (ARCT) delivered earnings and revenue surprises of 55.43% and 714.09%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Zealand Pharma AS (ZEAL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.